4 completed, 1 terminated, 1 withdrawn. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Immuron Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model. Travelan, Placebo - Diarrhea, Travelers Diarrhea | Phase 2 | Completed | Immuron Ltd. | 63 | 2023-05-29 | 2026-06-12 |
| Treatment for Clostridium-difficile Infection With IMM529 IMM-529, Placebo - Clostridium Difficile Infection, Clostridium Difficile Infection Recurrence | Phase 1 / Phase 2 | Terminated | Immuron Ltd. | 9 | 2017-09-01 | 2019-12-26 |
| Anti-LPS Antibody Treatment for Pediatric NAFLD IMM-124E, Placebo - Nonalcoholic Fatty Liver Disease (NAFLD) | Phase 2 | Completed | Miriam Vos, MD | 40 | 2017-02-01 | 2021-05-24 |
| Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis IMM 124-E (Hyperimmune Bovine Colostrum), Placebo (High protein milk powder) - Hepatitis, Alcoholic | Phase 2 | Completed | Virginia Commonwealth University | 57 | 2014-12-01 | 2020-01-27 |
| A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis IMM-124E, Placebo - Non-alcoholic Steatohepatitis (NASH) | Phase 2 | Completed | Immuron Ltd. | 133 | 2014-12-01 | 2020-02-21 |
| Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis IMM 124-E, Placebo - Nonalcoholic Steatohepatitis | Phase 2 | Withdrawn | Immuron Ltd. | 2012-12-01 | 2012-12-06 |
Non-alcoholic Fatty Liver Disease (3) · Clostridium Infections (1) · Diarrhea (1) · Dysentery (1) · Fatty Liver (1) · Hepatitis (1) · Hepatitis, Alcoholic (1)
United States (4) · Israel (2) · Australia (1)
Arun J Sanyal, MBBS MD (1) · Dan Peres (1) · Jerry Kanellos (1) · Miriam Vos, MD, MSPH (1) · Mohamed Al-Ibrahim, MB,ChB,FACP (1) · Neta Tobis (1)
PMID 34118361, PMID 36318027, PMID 41691535
U01AA021891 (1)